Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin

Abstract The relationship between familial amyloid polyneuropathy (FAP), which is caused by mutated transthyretin (TTR), and inflammation has only recently been noted. To determine whether inflammation is present in FAP carriers and patients, serum interleukin (IL)−6 concentration in 57 healthy dono...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Genki Suenaga, Tokunori Ikeda, Teruaki Masuda, Hiroaki Motokawa, Taro Yamashita, Kotaro Takamatsu, Yohei Misumi, Mitsuharu Ueda, Hirotaka Matsui, Satoru Senju, Yukio Ando
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5dbb39c113ac4fe3a3a9ceef389c870f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5dbb39c113ac4fe3a3a9ceef389c870f
record_format dspace
spelling oai:doaj.org-article:5dbb39c113ac4fe3a3a9ceef389c870f2021-12-02T16:06:26ZInflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin10.1038/s41598-017-01775-42045-2322https://doaj.org/article/5dbb39c113ac4fe3a3a9ceef389c870f2017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01775-4https://doaj.org/toc/2045-2322Abstract The relationship between familial amyloid polyneuropathy (FAP), which is caused by mutated transthyretin (TTR), and inflammation has only recently been noted. To determine whether inflammation is present in FAP carriers and patients, serum interleukin (IL)−6 concentration in 57 healthy donors (HD), 21 FAP carriers, and 66 FAP patients was examined, with the relationship between IL-6 and TTR assessed in each group by multiple regression analysis and structural equation models (SEM). Compared with HD, IL-6 concentration was elevated in FAP carriers (p = 0.001, 95% CI 0.398–1.571) and patients (p = 0.002, 95% CI 0.362–1.521). Further, SEM indicated a positive relationship between IL-6 and TTR in FAP carriers (p = 0.010, 95% CI 0.019–0.140), but not in HD and FAP patients. In addition, we determined whether TTR induces production of pro-inflammatory cytokines ex vivo. HD-derived CD14 + monocytes and induced pluripotent stem cell-derived myeloid lineage cells from a HD and FAP patient dose-dependently produced IL-6 under mutated and aggregated TTR conditions, compared with wild-type TTR. In conclusion, FAP carriers and patients are in an inflammatory state, with the presence of mutated TTR being a trigger of inflammation, especially in FAP carriers.Genki SuenagaTokunori IkedaTeruaki MasudaHiroaki MotokawaTaro YamashitaKotaro TakamatsuYohei MisumiMitsuharu UedaHirotaka MatsuiSatoru SenjuYukio AndoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Genki Suenaga
Tokunori Ikeda
Teruaki Masuda
Hiroaki Motokawa
Taro Yamashita
Kotaro Takamatsu
Yohei Misumi
Mitsuharu Ueda
Hirotaka Matsui
Satoru Senju
Yukio Ando
Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin
description Abstract The relationship between familial amyloid polyneuropathy (FAP), which is caused by mutated transthyretin (TTR), and inflammation has only recently been noted. To determine whether inflammation is present in FAP carriers and patients, serum interleukin (IL)−6 concentration in 57 healthy donors (HD), 21 FAP carriers, and 66 FAP patients was examined, with the relationship between IL-6 and TTR assessed in each group by multiple regression analysis and structural equation models (SEM). Compared with HD, IL-6 concentration was elevated in FAP carriers (p = 0.001, 95% CI 0.398–1.571) and patients (p = 0.002, 95% CI 0.362–1.521). Further, SEM indicated a positive relationship between IL-6 and TTR in FAP carriers (p = 0.010, 95% CI 0.019–0.140), but not in HD and FAP patients. In addition, we determined whether TTR induces production of pro-inflammatory cytokines ex vivo. HD-derived CD14 + monocytes and induced pluripotent stem cell-derived myeloid lineage cells from a HD and FAP patient dose-dependently produced IL-6 under mutated and aggregated TTR conditions, compared with wild-type TTR. In conclusion, FAP carriers and patients are in an inflammatory state, with the presence of mutated TTR being a trigger of inflammation, especially in FAP carriers.
format article
author Genki Suenaga
Tokunori Ikeda
Teruaki Masuda
Hiroaki Motokawa
Taro Yamashita
Kotaro Takamatsu
Yohei Misumi
Mitsuharu Ueda
Hirotaka Matsui
Satoru Senju
Yukio Ando
author_facet Genki Suenaga
Tokunori Ikeda
Teruaki Masuda
Hiroaki Motokawa
Taro Yamashita
Kotaro Takamatsu
Yohei Misumi
Mitsuharu Ueda
Hirotaka Matsui
Satoru Senju
Yukio Ando
author_sort Genki Suenaga
title Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin
title_short Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin
title_full Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin
title_fullStr Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin
title_full_unstemmed Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin
title_sort inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/5dbb39c113ac4fe3a3a9ceef389c870f
work_keys_str_mv AT genkisuenaga inflammatorystateexistsinfamilialamyloidpolyneuropathythatmaybetriggeredbymutatedtransthyretin
AT tokunoriikeda inflammatorystateexistsinfamilialamyloidpolyneuropathythatmaybetriggeredbymutatedtransthyretin
AT teruakimasuda inflammatorystateexistsinfamilialamyloidpolyneuropathythatmaybetriggeredbymutatedtransthyretin
AT hiroakimotokawa inflammatorystateexistsinfamilialamyloidpolyneuropathythatmaybetriggeredbymutatedtransthyretin
AT taroyamashita inflammatorystateexistsinfamilialamyloidpolyneuropathythatmaybetriggeredbymutatedtransthyretin
AT kotarotakamatsu inflammatorystateexistsinfamilialamyloidpolyneuropathythatmaybetriggeredbymutatedtransthyretin
AT yoheimisumi inflammatorystateexistsinfamilialamyloidpolyneuropathythatmaybetriggeredbymutatedtransthyretin
AT mitsuharuueda inflammatorystateexistsinfamilialamyloidpolyneuropathythatmaybetriggeredbymutatedtransthyretin
AT hirotakamatsui inflammatorystateexistsinfamilialamyloidpolyneuropathythatmaybetriggeredbymutatedtransthyretin
AT satorusenju inflammatorystateexistsinfamilialamyloidpolyneuropathythatmaybetriggeredbymutatedtransthyretin
AT yukioando inflammatorystateexistsinfamilialamyloidpolyneuropathythatmaybetriggeredbymutatedtransthyretin
_version_ 1718384962393079808